These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22483298)

  • 1. Catechol-O-methyl transferase as a drug target for schizophrenia.
    O'Tuathaigh CM; Desbonnet L; Lee P; Waddington JL
    CNS Neurol Disord Drug Targets; 2012 May; 11(3):282-91. PubMed ID: 22483298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.
    Apud JA; Weinberger DR
    CNS Drugs; 2007; 21(7):535-57. PubMed ID: 17579498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse facets of COMT: from a plausible predictive marker to a potential drug target for schizophrenia.
    Gupta M; Kaur H; Jajodia A; Jain S; Satyamoorthy K; Mukerji M; Thirthalli J; ; Kukreti R
    Curr Mol Med; 2011 Dec; 11(9):732-43. PubMed ID: 21999147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.
    Chen CY; Yeh YW; Kuo SC; Ho PS; Liang CS; Yen CH; Lu RB; Huang SY
    Psychoneuroendocrinology; 2016 Mar; 65():67-75. PubMed ID: 26724569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current understanding of the interplay between catechol-O-methyltransferase genetic variants, sleep, brain development and cognitive performance in schizophrenia.
    Tucci V; Lassi G; Kas MJ
    CNS Neurol Disord Drug Targets; 2012 May; 11(3):292-8. PubMed ID: 22483299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entacapone augmentation of antipsychotic treatment in schizophrenic patients with negative symptoms; a double-blind placebo-controlled study.
    Kaphzan H; Ben-Shachar D; Klein E
    Int J Neuropsychopharmacol; 2014 Feb; 17(2):337-40. PubMed ID: 24229565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.
    Gupta M; Bhatnagar P; Grover S; Kaur H; Baghel R; Bhasin Y; Chauhan C; Verma B; Manduva V; Mukherjee O; Purushottam M; Sharma A; Jain S; Brahmachari SK; Kukreti R
    Pharmacogenomics; 2009 Mar; 10(3):385-97. PubMed ID: 19290789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Genes in Schizophrenia and Their Importance in Choosing the Appropriate Antipsychotic Treatment.
    Werner FM; Coveñas R
    Curr Pharm Des; 2021 Oct; 27(30):3281-3292. PubMed ID: 33588721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COMT as a drug target for cognitive functions and dysfunctions.
    Scheggia D; Sannino S; Scattoni ML; Papaleo F
    CNS Neurol Disord Drug Targets; 2012 May; 11(3):209-21. PubMed ID: 22483296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol-O-methyl transferase and schizophrenia.
    Sagud M; Mück-Seler D; Mihaljević-Peles A; Vuksan-Cusa B; Zivković M; Jakovljević M; Pivac N
    Psychiatr Danub; 2010 Jun; 22(2):270-4. PubMed ID: 20562760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.
    Bertolino A; Caforio G; Blasi G; De Candia M; Latorre V; Petruzzella V; Altamura M; Nappi G; Papa S; Callicott JH; Mattay VS; Bellomo A; Scarabino T; Weinberger DR; Nardini M
    Am J Psychiatry; 2004 Oct; 161(10):1798-805. PubMed ID: 15465976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia.
    Illi A; Mattila KM; Kampman O; Anttila S; Roivas M; Lehtimäki T; Leinonen E
    J Clin Psychopharmacol; 2003 Oct; 23(5):429-34. PubMed ID: 14520117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients.
    Nour El Huda AR; Norsidah KZ; Nabil Fikri MR; Hanisah MN; Kartini A; Norlelawati AT
    Psychiatry Clin Neurosci; 2018 Apr; 72(4):266-279. PubMed ID: 29160620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal chemistry of catechol O-methyltransferase (COMT) inhibitors and their therapeutic utility.
    Kiss LE; Soares-da-Silva P
    J Med Chem; 2014 Nov; 57(21):8692-717. PubMed ID: 25080080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia.
    Illi A; Kampman O; Hänninen K; Anttila S; Mattila KM; Katila H; Rontu R; Hurme M; Lehtimäki T; Leinonen E
    Hum Psychopharmacol; 2007 Jun; 22(4):211-5. PubMed ID: 17526059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase and Parkinson's disease.
    Tai CH; Wu RM
    Acta Med Okayama; 2002 Feb; 56(1):1-6. PubMed ID: 11873938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enzymatic activities of brain catechol-O-methyltransferase (COMT) and methionine sulphoxide reductase are correlated in a COMT Val/Met allele-dependent fashion.
    Moskovitz J; Walss-Bass C; Cruz DA; Thompson PM; Hairston J; Bortolato M
    Neuropathol Appl Neurobiol; 2015 Dec; 41(7):941-51. PubMed ID: 25640985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
    Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
    Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond.
    Tunbridge EM; Harrison PJ; Weinberger DR
    Biol Psychiatry; 2006 Jul; 60(2):141-51. PubMed ID: 16476412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.